文献速递消化道肿瘤与早癌消化内镜

筛查性结肠镜检查降低左右半结肠癌死亡风险的有效性:一项大型社区研究

Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.
PubMed 文献 · Gut · 2016-10-12

在Kaiser Permanente筛查合格成员中开展的巢式病例对照研究显示,与未接受内镜筛查相比,接受筛查性结肠镜检查与任何结直肠癌死亡风险降低67%相关(aOR=0.33,95%CI 0.21-0.52),右半结肠癌死亡风险降低65%(aOR=0.35,95%CI 0.18-0.65),左半结肠/直肠癌死亡风险降低75%(aOR=0.25,95%CI 0.12-0.53)。

要点

  • 筛查性结肠镜检查与任何结直肠癌死亡风险降低67%相关(aOR=0.33,95%CI 0.21-0.52)。
  • 右半结肠癌死亡风险降低65%(aOR=0.35,95%CI 0.18-0.65)。
  • 左半结肠/直肠癌死亡风险降低75%(aOR=0.25,95%CI 0.12-0.53)。

核心结论

  • 在大型社区人群中,筛查性结肠镜检查与右半结肠癌和左半结肠癌死亡风险均呈现大幅且程度相近的降低相关。

研究设计与样本

  • 采用巢式病例对照研究,在筛查合格的Kaiser Permanente成员中按发病密度匹配。
  • 病例为2006-2012年因结直肠癌死亡、死亡时年龄55-90岁的患者,对照按诊断(参考)日期、年龄、性别、健康计划入组时长和地理区域匹配。
  • 排除结直肠癌风险增高、既往结直肠癌诊断或结肠切除术的患者。
  • 分析1747例结直肠癌死亡患者和3460例无结直肠癌对照。

主要发现

  • 与未接受内镜筛查相比,接受筛查性结肠镜检查与任何结直肠癌死亡风险降低67%相关(aOR=0.33,95%CI 0.21-0.52)。
  • 按肿瘤部位,筛查性结肠镜检查与右半结肠癌死亡风险降低65%相关(aOR=0.35,95%CI 0.18-0.65)。
  • 筛查性结肠镜检查与左半结肠/直肠癌死亡风险降低75%相关(aOR=0.25,95%CI 0.12-0.53)。

关键数值与推荐

  • 任何结直肠癌死亡:aOR=0.33(95%CI 0.21-0.52),对应风险降低67%。
  • 右半结肠癌死亡:aOR=0.35(95%CI 0.18-0.65),对应风险降低65%。
  • 左半结肠/直肠癌死亡:aOR=0.25(95%CI 0.12-0.53),对应风险降低75%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Screening colonoscopy's effectiveness in reducing colorectal cancer mortality risk in community populations is unclear, particularly for right-colon cancers, leading to recommendations against its use for screening in some countries. This study aimed to determine whether, among average-risk people, receipt of screening colonoscopy reduces the risk of dying from both right-colon and left-colon/rectal cancers. DESIGN: We conducted a nested case-control study with incidence-density matching in screening-eligible Kaiser Permanente members. Patients who were 55-90 years old on their colorectal cancer death date during 2006-2012 were matched on diagnosis (reference) date to controls on age, sex, health plan enrolment duration and geographical region. We excluded patients at increased colorectal cancer risk, or with prior colorectal cancer diagnosis or colectomy. The association between screening colonoscopy receipt in the 10-year period before the reference date and colorectal cancer death risk was evaluated while accounting for other screening exposures. RESULTS: We analysed 1747 patients who died from colorectal cancer and 3460 colorectal cancer-free controls. Compared with no endoscopic screening, receipt of a screening colonoscopy was associated with a 67% reduction in the risk of death from any colorectal cancer (adjusted OR (aOR)=0.33, 95% CI 0.21 to 0.52). By cancer location, screening colonoscopy was associated with a 65% reduction in risk of death for right-colon cancers (aOR=0.35, CI 0.18 to 0.65) and a 75% reduction for left-colon/rectal cancers (aOR=0.25, CI 0.12 to 0.53). CONCLUSIONS: Screening colonoscopy was associated with a substantial and comparably decreased mortality risk for both right-sided and left-sided cancers within a large community-based population.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2016. PMID: 27733426. doi:10.1136/gutjnl-2016-312712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。